Literature DB >> 12663800

Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.

Gavin Morrow1, Barry Slobedman, Anthony L Cunningham, Allison Abendroth.   

Abstract

Mature dendritic cells (DCs) are potent antigen-presenting cells essential for initiating successful antiviral immune responses and would therefore serve as an ideal target for viruses seeking to evade or delay the immune response by disrupting their function. We have previously reported that VZV productively infects immature DCs (A. Abendroth, G. Morrow, A. L. Cunningham, and B. Slobedman, J. Virol. 75:6183-6192, 2001), and in the present study we assessed the ability of VZV to infect mature DCs. Mature DCs were generated from immature monocyte-derived DCs by lipopolysaccharide treatment before being exposed to VZV-infected fibroblasts. On day 4 postexposure, flow cytometry analysis revealed that 15 to 45% of mature DCs were VZV antigen positive, and immunofluorescent staining together with infectious-center assays demonstrated that these cells were fully permissive for the complete VZV replicative cycle. VZV infection of mature DCs resulted in a selective downregulation of cell surface expression of the functionally important immune molecules major histocompatibility complex (MHC) class I, CD80, CD83, and CD86 but did not alter MHC class II expression. Immunofluorescent staining showed that the downregulation of cell surface CD83 was concomitant with a retention of CD83 in cytoplasmic vesicles. Importantly, VZV infection of mature DCs significantly reduced their ability to stimulate the proliferation of allogeneic T lymphocytes. These data demonstrate that mature DCs are permissive for VZV and that infection of these cells reduces their ability to function properly. Thus, VZV has evolved yet another immune evasion strategy that would likely impair immunosurveillance and enhance the chances for lifelong persistence in the human population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663800      PMCID: PMC152143          DOI: 10.1128/jvi.77.8.4950-4959.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  CD83 on dendritic cells: more than just a marker for maturation.

Authors:  Matthias Lechmann; Susanne Berchtold; Joachim Hauber; Alexander Steinkasserer
Journal:  Trends Immunol       Date:  2002-06       Impact factor: 16.687

3.  Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy.

Authors:  M J Raftery; M Schwab; S M Eibert; Y Samstag; H Walczak; G Schönrich
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

4.  Inhibition of dendritic cell maturation by herpes simplex virus.

Authors:  M Salio; M Cella; M Suter; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

5.  Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.

Authors:  A Abendroth; I Lin; B Slobedman; H Ploegh; A M Arvin
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host.

Authors:  A Abendroth; G Morrow; A L Cunningham; B Slobedman
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity.

Authors:  M Kruse; O Rosorius; F Krätzer; G Stelz; C Kuhnt; G Schuler; J Hauber; A Steinkasserer
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Authors:  Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita; Masaki Yasukawa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells.

Authors:  N Sevilla; S Kunz; A Holz; H Lewicki; D Homann; H Yamada; K P Campbell; J C de La Torre; M B Oldstone
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

10.  Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells.

Authors:  I Fugier-Vivier; C Servet-Delprat; P Rivailler; M C Rissoan; Y J Liu; C Rabourdin-Combe
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

View more
  53 in total

1.  Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.

Authors:  Cindy Gutzeit; Martin J Raftery; Matthias Peiser; Karsten B Tischer; Martina Ulrich; Melanie Eberhardt; Eggert Stockfleth; Thomas Giese; Andreas Sauerbrei; Craig T Morita; Günther Schönrich
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

2.  L Particles Transmit Viral Proteins from Herpes Simplex Virus 1-Infected Mature Dendritic Cells to Uninfected Bystander Cells, Inducing CD83 Downmodulation.

Authors:  Christiane S Heilingloh; Mirko Kummer; Petra Mühl-Zürbes; Christina Drassner; Christoph Daniel; Monika Klewer; Alexander Steinkasserer
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

3.  Latent Kaposi's sarcoma-associated herpesvirus infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokines.

Authors:  Sean M Gregory; Ling Wang; John A West; Dirk P Dittmer; Blossom Damania
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 4.  Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.

Authors:  Emmanuel J Wiertz; Robert Devlin; Helen L Collins; Maaike E Ressing
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

5.  Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase.

Authors:  Amie J Eisfeld; Stephanie E Turse; Sara A Jackson; Edwina C Lerner; Paul R Kinchington
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Infection and Functional Modulation of Human Monocytes and Macrophages by Varicella-Zoster Virus.

Authors:  Megan Steain; Barry Slobedman; Allison Abendroth; Jarrod J Kennedy
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

7.  Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Ramon Arens; Rachel Flynn; Alessandro Sette; Stephen P Schoenberger; Michael Croft
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: a novel mechanism for AIDS pathogenesis.

Authors:  Laura Fantuzzi; Cristina Purificato; Karim Donato; Filippo Belardelli; Sandra Gessani
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells.

Authors:  Pablo A González; Carolina E Prado; Eduardo D Leiva; Leandro J Carreño; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

10.  Receptor-dependent coronavirus infection of dendritic cells.

Authors:  Brian C Turner; Erin M Hemmila; Nicole Beauchemin; Kathryn V Holmes
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.